Manufacturing drug co-loaded liposomal formulations targeting breast cancer: Influence of preparative method on liposomes characteristics and in vitro toxicity. (2020)
Attributed to:
Developing personalized nanotherapies to target placental abnormalities causing fetal growth restriction
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.ijpharm.2020.119926
PubMed Identifier: 33010397
Publication URI: http://europepmc.org/abstract/MED/33010397
Type: Journal Article/Review
Volume: 590
Parent Publication: International journal of pharmaceutics
ISSN: 0378-5173